Quarterly Report • Feb 23, 2022
Quarterly Report
Open in ViewerOpens in native device viewer
Q4 Presentation 23rd February 2022
This presentation is the managements summary of the 4th quarter report, it includes forward-looking statements that reflect the Company's current views with respect to future events and financial and operational performance. These forward-looking statements may be identified by the use of forward-looking terminology.
These forward-looking statements are not historic facts. The forward-looking statements are not guarantees of future performance. The Company's actual financial position, operating results and liquidity, and the development of the industry in which the Company operates, may differ materially from those made in, or suggested, by the forward-looking statements.
The Company cannot guarantee that the intentions, beliefs, or current expectations upon which its forward-looking statements are based will occur.
By their nature, forward-looking statements involve, and are subject to, known and unknown risks, uncertainties, and assumptions as they relate to events and depend on circumstances that may or may not occur in the future. Because of these known and unknown risks, uncertainties and assumptions, the outcome may differ materially from those set out in the forward-looking statements.
These forward-looking statements speak only as at the date on which they are made. The Company undertakes no obligation to publicly update or publicly revise any forward-looking statement, whether as a result of new information, future events or otherwise. All subsequent written and oral forward-looking statements attributable to the Company or to persons acting on the Company's behalf are expressly qualified in their entirety by the cautionary statements referred to above and contained elsewhere in this presentation.
| 1 | Highlights for the period |
|---|---|
| 2 | Operational performance & Group financials |
| 3 | Building blocks |
| 4 | Markets |
| 5 | Growth projects |
| 6 | Outlook and summary |
• Historically the largest year in terms of sales volume Harvested 2,938 tonnes in the quarter, bringing the year total to 11,479 tonnes harvested – a 54% increase YoY. • Farming EBIT of 10.1 NOK pr.kg - an improvement of 14.7 NOK pr. kg from Q4 20. • The growth developed positively YoY (3.2% increase), growing 4,015 tonnes compared to 3,890 in Q4 20. • Arctic Fish continues to deliver a high percentage (96.7%) of superior quality salmon to the market. • Improved price achievement having a positive effect on the Farming EBIT pr. kg.
| 1 | Highlights for the period | |||
|---|---|---|---|---|
| 2 | Operational performance & Group financials | |||
| 3 | Building blocks | |||
| 4 | Markets | |||
| 5 | Growth projects | |||
| 6 | Outlook and summary |
Expecting higher production costs in Q1 22 due to the Dyrafjordur incident.
Biomass in sea increased by 4.9% QoQ and increased by 964 tonnes LW (9%) from Q4 20.
As previously stated, the compromised fish health and consequent mortalities in Dyrafjordur is thought to have been caused by the following:
| Key figures from P/L | |||
|---|---|---|---|
| -- | ---------------------- | -- | -- |
| KEY FIGURES | Q4 | Q4 | FY | FY |
|---|---|---|---|---|
| (NOK '000) | 2021 | 2020 | 2021 | 2020 |
| Operating revenues | 166.253 | 130.509 | 595.895 | 375.667 |
| Operational EBIT | 27.530 | -11.706 | 86.944 | 6.319 |
| Fair value adjustments | -13.940 | -4.638 | 44.897 | -4.638 |
| Production tax | -790 | 0 | -3.843 | -312 |
| EBIT | 12.800 | -16.344 | 127.998 | 1.369 |
| Net financial items | 294 | -20.799 | 2.580 | -39.870 |
| Earnings before tax (EBT) | 13.094 | -37.143 | 130.578 | -38.500 |
| Earnings per share | 1,10 | -1,17 | 4,79 | -1,21 |
| Volume harvested GW | 2.938 | 2.988 | 11.479 | 7.443 |
| Operational EBIT pr.kg (farming) | 10,05 | -4,62 | 8,67 | 0,64 |
| Key figures from Balance sheet | |||||
|---|---|---|---|---|---|
| KEY FIGURES | |||||
| (NOK '000) | 31.12.2021 | 30.9.2021 | 31.12.2020 | ||
| Intangible assets | 52.119 | 49.340 | 34.297 | ||
| Deferred tax assets | 19.479 | ||||
| Property, plant and equipment | 657.161 | 605.124 | 559.988 | ||
| Right of use assets | 4.435 | 0 | 0 | ||
| Non-current financial assets | 629 | 629 | 626 | ||
| Non-current assets | 733.824 | 655.094 | 594.911 | ||
| Biological assets | 512.010 | 496.880 | 429.237 | ||
| Other inventory | 33.785 | 18.800 | |||
| Receivables | 115.951 | 76.480 | 34.528 | ||
| Bank deposits | 38.126 | 55.517 | 79.171 | ||
| Current assets | 699.871 | 647.676 | 542.936 | ||
| TOTAL ASSETS | 1.433.695 | 1.302.770 | 1.137.847 | ||
| Equity | 975.508 | 940.429 | 478.805 | ||
| Provisions | 0 | 2.506 | 2.506 | ||
| Interest-bearing debt | 354.215 | 238.342 | 548.844 | ||
| Long term leasing liabilities | 3.424 | 0 | 0 | ||
| Short term leasing liabilities | 1.138 | 0 | 0 | ||
| Trade payables | 91.052 | 112.110 | 100.703 | ||
| Other current liabilities | 8.357 | 9.384 | 9.495 | ||
| TOTAL EQUITY AND LIABILITIES | 1.433.695 | 1.302.770 | 1.137.847 |
| NET INTEREST BEARING DEBT |
|||
|---|---|---|---|
| (NOK '000) | 31.12.2021 | 30.9.2021 | 31.12.2020 |
| Reported long term interest bearing debt | 318.152 | 201.720 | 245.184 |
| Reported short term interest bearing debt | 36.063 | 36.621 | 301.154 |
| Reported bank deposits | 38.126 - - |
55.517 - | 79.171 |
| Total net interest bearing debt | 316.090 | 182.825 | 467.167 |
| EQUITY RATIO |
|||||
|---|---|---|---|---|---|
| (NOK '000) | 31.12.2021 | 30.9.2021 | 31.12.2020 | ||
| Reported equity | 975.508 | 940.429 | 478.805 | ||
| Reported total assets | 1.433.695 | 1.302.770 | 1.137.847 | ||
| Equity ratio |
68,0% | 72,2% | 42,1% |
| INTEREST BEARING DEBT OVERVIEW | ||||
|---|---|---|---|---|
| (NOK '000) | 31.12.2021 | 30.9.2021 | Loan agreement Unused 31.12.2021 | |
| Total interest bearing debt | 354.215 | 238.342 | 781.432 | 427.217 |
• Net interest bearing debt up by 133 MNOK in the quarter due to an increase in working capital and fixed assets.
| Ongoing investments | Planned capital expenditure going forward | ||||
|---|---|---|---|---|---|
| • Expansion of smolt capacity |
Planned Capital Expenditures (MNOK) | ||||
| • Farming equipment |
600 | 565 | |||
| • Branding initiatives |
500 | ||||
| • Biomass build-up |
400 | ||||
| • Increase harvesting capacity |
300 | ||||
| • Within the 2022 Capex there are still pending final decisions by the BOD about a 230 |
200 161 |
155 | |||
| MNOK investment in a new harvesting project. Final decision to be made in Q1 2022. |
100 | ||||
| 0 |
2021 2022 2023
| 1 | Highlights for the period |
|---|---|
| 2 | Operational performance & Group financials |
| 3 | Building blocks |
| 4 | Markets |
| 5 | Growth projects |
| 6 | Outlook and summary |
First of its kind hi-tech smolt facility with 100% green energy
No antibiotics has ever been used on Arctic Fish sites
Arctic Fish strives to use non-medical methods to battle sea and fish lice
II
New 4,000 tonnes (MAB) license in Arnarfjörður had already advertised to be issued, a new license in a new site and new fjord for Arctic Fish. The licenses are expected to be issued and granted in Q2 2022. The issuing agencies are delayed (from the previously stated Q4 2021) due to legal and technical inefficiencies that influence all issuance of salmon farming licenses in Iceland.
Arctic Fish has pending applications in the final stages for additional 4.8kt MAB in Ísafjarðardjúp.
It is expected that the current existing MAB for trout farming up to 5.3 thousand tonnes will be converted to salmon in the same process.
The licenses are expected to be issued and granted in Q2 2022. The issuing agencies are delayed to legal and technical inefficiencies that influence all issuance of salmon farming licenses in Iceland.
| 1 | Highlights for the period |
|---|---|
| 2 | Operational performance & Group financials |
| 3 | Building blocks |
| 4 | Markets |
| 5 | Growth projects |
| 1 | Highlights for the period | ||||
|---|---|---|---|---|---|
| 2 | Operational performance & Group financials | ||||
| 3 | Building blocks | ||||
| 4 | Markets | ||||
| 5 | Growth projects | ||||
| 6 | Outlook and summary |
Project on track, timeline and cost P wise
Increased harvesting capacity
A new facility has been purchased that can be ready for operation in the first quarter of 2023 P
| 1 | Highlights for the period | ||||
|---|---|---|---|---|---|
| 2 | Operational performance & Group financials | ||||
| 3 | Building blocks | ||||
| 4 | Markets | ||||
| 5 | Growth projects | ||||
| 6 | Outlook and summary |
Harvested quantity in Q4 decreased 2% YoY:
2020 Q4: 2,988 tonnes 2021 Q4: 2,938 tonnes
Total harvested quantity increased by 54% YoY:
2020: 7,443 tonnes
2021: 11,479 tonnes
2022E: 10,100 tonnes
| Q4 | Q4 | FY | FY | |
|---|---|---|---|---|
| (NOK '000) | 2021 | 2020 | 2021 | 2020 |
| Operating revenues | 166.253 | 130.509 | 595.895 | 375.667 |
| Cost of goods sold | 90.732 | 92.956 | 299.189 | 192.800 |
| Salaries | 11.526 | 11.932 | 54.151 | 42.025 |
| Depreciation | 12.940 | 11.755 | 46.501 | 40.113 |
| Other operating costs | 23.526 | 25.572 | 109.110 | 94.410 |
| Operational EBIT | 27.530 | -11.706 | 86.944 | 6.319 |
| Fair value adjustments | -13.940 | -4.638 | 44.897 | -4.638 |
| Production tax | -790 | 0 | -3.843 | -312 |
| EBIT | 12.800 | -16.344 | 127.998 | 1.369 |
| Other net financial items | 294 | -20.799 | 2.580 | -39.870 |
| Earnings before tax (EBT) | 13.094 | -37.143 | 130.578 | -38.500 |
| Taxes | 21.985 | 0 | 21.985 | 0 |
| Net profit/loss | 35.079 | -37.143 | 152.563 | -38.500 |
| Profit attributable to: | ||||
| Parent company shareholders | 35.079 | -37.143 | 152.563 | -38.500 |
| Minority interests | 0 | 0 | 0 | 0 |
| Earnings per share (NOK) | 1,10 | -1,17 | 4,79 | -1,21 |
| Earnings per share - diluted |
1,10 | -1,17 | 4,79 | -1,21 |
| COMPREHENSIVE INCOME STATEMENT | ||||
| Q4 | Q4 | FY | FY | |
| (NOK '000) | 2021 | 2020 | 2021 | 2020 |
| Net profit/loss | 35.079 | -37.143 | 152.563 | -38.500 |
| Total comprehensive income | 35.079 | -37.143 | 152.563 | -38.500 |
| Total comprehensive income attributable to: | ||||
| Parent company shareholders | 35.079 | -37.143 | 152.563 | -38.500 |
| (NOK '000) | 31.12.2021 | 30.9.2021 | 31.12.2020 |
|---|---|---|---|
| Deferred tax assets | 19.479 | 0 | 0 |
| Intangible assets | 52.119 | 49.340 | 34.297 |
| Property, plant and equipment | 657.161 | 605.124 | 559.988 |
| Right of use assets | 4.435 | 0 | 0 |
| Non-current financial assets | 629 | 629 | 626 |
| Non-current assets | 733.824 | 655.094 | 594.911 |
| Biological assets | 512.010 | 496.880 | 402.191 |
| Other inventory | 33.785 | 18.800 | 27.046 |
| Receivables | 115.951 | 76.480 | 34.528 |
| Bank deposits | 38.126 | 55.517 | 79.171 |
| Current assets | 699.871 | 647.676 | 542.936 |
| TOTAL ASSETS | 1.433.695 | 1.302.770 | 1.137.847 |
| Share capital | 31.877 | 31.877 | 689.476 |
| Other equity | 943.631 | 908.552 | -210.672 |
| Equity | 975.508 | 940.429 | 478.805 |
| Deferred tax | 0 | 2.506 | 2.506 |
| Provisions | 0 | 2.506 | 2.506 |
| Long-term interest-bearing debt | 318.152 | 201.720 | 245.184 |
| Long term leasing liabilities | 3.424 | 0 | 0 |
| Short-term interest-bearing debt | 36.063 | 36.621 | 301.154 |
| Short term leasing liabilities | 1.138 | 0 | 0 |
| Trade payables | 91.052 | 112.110 | 100.703 |
| Other current liabilities | 8.357 | 9.384 | 9.495 |
| Current liabilities | 136.610 | 158.115 | 411.353 |
| TOTAL EQUITY AND LIABILITIES | 1.433.695 | 1.302.770 | 1.137.847 |
| 31.12.2021 | Equity allocated to parent company shareholders |
Non | ||||
|---|---|---|---|---|---|---|
| Treasury | Retained | controlling | ||||
| (NOK '000) | Share capital | shares | earnings | Total | interests | Total equity |
| Equity at 01.01.2021 | 689.476 | 0 | -210.672 | 478.805 | 0 | 478.805 |
| Total comprehensive income | 0 | 0 | 152.563 | 152.563 | 0 | 152.563 |
| Transactions with shareholders | ||||||
| Reclassification due to new parent | -689.476 | 12.888 | -676.588 | -676.588 | ||
| Issued share capital | 26.158 | 650.431 | 676.588 | 676.588 | ||
| Issued share capital | 5.719 | 344.281 | 350.000 | 350.000 | ||
| Transaction costs | -5.859 | -5.859 | -5.859 | |||
| Total transactions with shareholders | -657.600 | 0 | 1.001.740 | 344.141 | 0 | 344.141 |
| Equity at 31.12.2021 | 31.877 | 0 | 943.632 | 975.508 | 0 | 975.508 |
| 31.12.2020 | Equity allocated to parent company shareholders |
Non | ||||
|---|---|---|---|---|---|---|
| (NOK '000) | Share capital | Treasury shares |
Retained earnings |
Total | controlling interests |
Total equity |
| Equity at 31.12.2019 (ICEGAAP) | 457.719 | 0 | -189.415 | 268.304 | 0 | 268.304 |
| Effect of implementation IFRS | 17.244 | 17.244 | 17.244 | |||
| Equity at 01.01.2020 (IFRS) | 457.719 | 0 | -172.171 | 285.548 | 0 | 285.548 |
| Total comprehensive income | 0 | 0 | -38.500 | -38.500 | 0 | -38.500 |
| Transactions with shareholders | ||||||
| Issued share capital | 231.757 | 231.757 | 231.757 | |||
| Total transactions with shareholders | 231.757 | 0 | 0 | 231.757 | 0 | 231.757 |
| Equity at 31.12.2020 | 689.476 | 0 | -210.672 | 478.805 | 0 | 478.805 |
| Q4 | Q4 | FY | FY | |
|---|---|---|---|---|
| (NOK '000) | 2021 | 2020 | 2021 | 2020 |
| Operational EBIT | 27.218 | -11.706 | 86.944 | 6.319 |
| Adjusted for: | ||||
| Depreciation | 12.940 | 11.755 | 46.501 | 40.113 |
| Production tax | -790 | 0 | -3.843 | -312 |
| Change in inventories/biological assets | -44.055 | -16.925 | -71.661 | -146.716 |
| Change in account receivables and accounts payables | -60.528 | 24.515 | -91.074 | 69.957 |
| Change in other current assets and liabilities | -1.026 | 1.349 | -1.138 | 5.856 |
| Net cash flow from operating activities | -65.930 | 8.988 | -34.271 | -24.782 |
| Cash flow from investing activities | ||||
| Payments for purchase of fixed assets and licenses (MAB) |
-67.101 | -28.872 | -160.846 | -99.705 |
| Net cash flow from investing activities | -67.101 | -28.872 | -160.846 | -99.705 |
| Cash flow from financing activities | ||||
| Proceeds from borrowings | 119.797 | 518.424 | 119.797 | 597.944 |
| Repayment of borrowings | -9 | -590.948 | -69.747 | -622.640 |
| Installments on right to use liabilities | -528 | 0 | -528 | 0 |
| Interest payments for right to use liabilities | -153 | 0 | -153 | 0 |
| Current debt change | -3.914 | -93.466 | -242.172 | 26.306 |
| Issued new share capital | 0 | 231.757 | 344.140 | 231.757 |
| Net interest payments | -5.812 | -20.799 | -22.311 | -39.870 |
| Adjustment due to Currency difference | 6.259 | 0 | 25.044 | 0 |
| Net cash flow from financing activities | 115.640 | 44.968 | 154.071 | 193.497 |
| Net increase in bank deposits | -17.391 | 25.084 | -41.046 | 69.010 |
| Bank deposits as of start of period |
55.517 | 54.088 | 79.171 | 10.162 |
| Bank deposits as of 31st of December | 38.126 | 79.171 | 38.126 | 79.171 |
Ownership structure: The largest 20 shareholders as of 31.12.2021*
| Rank | Name | # of shares | % ownership |
|---|---|---|---|
| 1 | NORWAY ROYAL SALMON ASA | 16.346.824 | 51,28% |
| 2 | BREMESCO HOLDINGS LIMITED | 9.104.582 | 28,56% |
| 3 | J.P. Morgan Bank Luxembourg S.A. | 3.031.424 | 9,51% |
| 4 | Landsbankinn hf. | 519.716 | 1,63% |
| 5 | VERDIPAPIRFONDET PARETO INVESTMENT | 351.000 | 1,10% |
| 6 | KVERVA FINANS AS | 258.000 | 0,81% |
| 7 | VERDIPAPIRFONDET NORDEA AVKASTNING | 237.107 | 0,74% |
| 8 | VERDIPAPIRFONDET NORDEA KAPITAL | 193.100 | 0,61% |
| 9 | CLEARSTREAM BANKING S.A. | 181.391 | 0,57% |
| 10 | VERDIPAPIRFONDET EIKA SPAR | 172.312 | 0,54% |
| 11 | MP PENSJON PK | 165.000 | 0,52% |
| 12 | PACTUM AS | 152.751 | 0,48% |
| 13 | VERDIPAPIRFONDET EIKA NORGE | 125.225 | 0,39% |
| 14 | J.P. Morgan Bank Luxembourg S.A. | 83.849 | 0,26% |
| 15 | VERDIPAPIRFONDET NORDEA NORGE PLUS | 82.702 | 0,26% |
| 16 | State Street Bank and Trust Comp | 80.605 | 0,25% |
| 17 | ROTH | 80.000 | 0,25% |
| 18 | Euroclear Bank S.A./N.V. | 68.154 | 0,21% |
| 19 | VERDIPAPIRFONDET HOLBERG TRITON | 50.733 | 0,16% |
| 20 | TRETHOM AS | 41.101 | 0,13% |
| Ownership of 20 largest shareholders | 31.325.576 | 98,27% | |
| Total number of shares | 31.876.653 | 100,00% |
Arctic Fish Holding does not own any of it's shares
*20 largest shareholders list includes nominee accounts that are composed of multiple individual shareholders.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.